Lexaria Bioscience (LEXX) Tax Rate (2025 - 2026)

Lexaria Bioscience (LEXX) posted Tax Rate of 0.0% for Q2 2026, up 99.61% sequentially from 0.18% in Q1 2026.

Lexaria Bioscience (LEXX) Tax Rate (2025 - 2026) Analysis & Trends

Lexaria Bioscience has reported Tax Rate for 2 years, with the latest figure at 0.0% in Q2 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	138.71 Bn	130.86 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	85.60 Bn	77.60 Bn	3.93 Bn	15.11%
3	Argenx Se	64.82 Bn	59.63 Bn	1.37 Bn	10.91%
4	Moderna	57.92 Bn	52.79 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.88 Bn	36.78 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	31.46 Bn	28.15 Bn	992.69 Mn	7.49%
7	BioNTech SE	27.96 Bn	9.57 Bn	668.28 Mn	34.12%
8	Insmed	27.35 Bn	26.19 Bn	358.27 Mn	-16.71%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Lexaria Bioscience	10.15 Mn	6.54 Mn	-	0.00%

Download Data